Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study (Q49186640)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

0 references

author name string

William E Gillanders

1

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Kaidi Mikhitarian

2

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Renee Hebert

3

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Patrick D Mauldin

4

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Yuko Palesch

5

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Christian Walters

6

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Marshall M Urist

7

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

G Bruce Mann

8

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Gerard Doherty

9

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Virginia M Herrmann

10

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Arnold D Hill

11

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Oleg Eremin

12

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Mohamed El-Sheemy

13

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Richard K Orr

14

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Alvaro A Valle

15

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Michael A Henderson

16

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Robert L Dewitty

17

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Sonia L Sugg

18

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Eric Frykberg

19

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Karen Yeh

20

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Richard M Bell

21

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

John S Metcalf

22

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Bruce M Elliott

23

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Thomas Brothers

24

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Jay Robison

25

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Michael Mitas

26

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

David J Cole

27

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

239

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

6

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

828-37; discussion 837-40

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Prognostic impact of tumor biological factors on survival in node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Putative markers for the detection of breast carcinoma cells in blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Occult axillary node metastases in breast cancer: their detection and prognostic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

26 August 2018

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1356291

1 December 2018

Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent prognostication and therapy monitoring of breast cancer patients by DNA/RNA typing of minimal residual cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are positive axillary nodes in breast cancer markers for incurable disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammaglobin expression in primary, metastatic, and occult breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammaglobin, a potential marker of breast cancer nodal metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/15166962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/01.SLA.0000128687.59439.D6

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15166962

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49186640&oldid=2223937180"